Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    16924027 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Recruiting Incobotulinum Toxin A (Xeomin®) As A Treatment For Focal Task-Specific Dystonia Of The Musician's Hand
Condition: Dystonia
Intervention: Drug: incobotulinumtoxin A

Indicates status has not been verified in more than two years